Birchview Capital as of Sept. 30, 2019
Portfolio Holdings for Birchview Capital
Birchview Capital holds 50 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 46.3 | $70M | 700k | 99.30 | |
Accelr8 Technology | 27.0 | $41M | 2.2M | 18.57 | |
Neurocrine Biosciences (NBIX) | 3.3 | $5.0M | 55k | 90.11 | |
Eqt Midstream Partners | 2.2 | $3.3M | 101k | 32.70 | |
Quidel Corporation | 2.0 | $3.0M | 49k | 61.36 | |
Oxford Immunotec Global | 1.9 | $2.8M | 170k | 16.63 | |
Bristol Myers Squibb (BMY) | 1.6 | $2.4M | 47k | 50.70 | |
Vermillion | 1.1 | $1.7M | 3.2M | 0.52 | |
Dova Pharmaceuticals | 0.9 | $1.4M | 50k | 27.96 | |
Masimo Corporation (MASI) | 0.8 | $1.2M | 8.0k | 148.75 | |
Biogen Idec (BIIB) | 0.8 | $1.2M | 5.0k | 232.80 | |
Vanda Pharmaceuticals (VNDA) | 0.7 | $1.1M | 80k | 13.28 | |
Arena Pharmaceuticals | 0.7 | $1.0M | 22k | 45.77 | |
Harrow Health (HROW) | 0.7 | $1.0M | 180k | 5.62 | |
G1 Therapeutics (GTHX) | 0.6 | $911k | 40k | 22.78 | |
Amarin Corporation (AMRN) | 0.6 | $894k | 59k | 15.15 | |
Myriad Genetics (MYGN) | 0.6 | $859k | 30k | 28.63 | |
Dermira | 0.5 | $767k | 120k | 6.39 | |
Albireo Pharma | 0.5 | $760k | 38k | 20.00 | |
Acceleron Pharma | 0.5 | $738k | 19k | 39.52 | |
Corcept Therapeutics Incorporated (CORT) | 0.5 | $707k | 50k | 14.14 | |
Karyopharm Therapeutics (KPTI) | 0.5 | $673k | 70k | 9.61 | |
Arvinas Ord (ARVN) | 0.4 | $647k | 30k | 21.57 | |
Wright Medical | 0.4 | $619k | 30k | 20.63 | |
Dicerna Pharmaceuticals | 0.4 | $574k | 40k | 14.35 | |
Intercept Pharmaceuticals In | 0.4 | $551k | 8.3k | 66.39 | |
Odonate Therapeutics Ord | 0.3 | $521k | 20k | 26.05 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $504k | 14k | 36.00 | |
Voyager Therapeutics (VYGR) | 0.3 | $516k | 30k | 17.20 | |
Pioneer Natural Resources (PXD) | 0.3 | $478k | 3.8k | 125.79 | |
ImmunoGen | 0.3 | $436k | 180k | 2.42 | |
Xencor (XNCR) | 0.3 | $415k | 12k | 33.74 | |
Veracyte (VCYT) | 0.2 | $378k | 16k | 23.97 | |
Soleno Therapeutics | 0.2 | $361k | 241k | 1.50 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $348k | 30k | 11.60 | |
Xbiotech (XBIT) | 0.2 | $314k | 30k | 10.47 | |
Amicus Therapeutics (FOLD) | 0.2 | $305k | 38k | 8.03 | |
Sientra | 0.2 | $259k | 40k | 6.48 | |
Continental Resources | 0.2 | $246k | 8.0k | 30.75 | |
Lexicon Pharmaceuticals (LXRX) | 0.2 | $241k | 80k | 3.01 | |
Encana Corp | 0.1 | $228k | 50k | 4.60 | |
Mereo Biopharma Group Plc ads (MREO) | 0.1 | $231k | 78k | 2.98 | |
Cytokinetics (CYTK) | 0.1 | $114k | 10k | 11.40 | |
Tg Therapeutics (TGTX) | 0.1 | $84k | 15k | 5.60 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $88k | 25k | 3.52 | |
Contrafect | 0.1 | $82k | 227k | 0.36 | |
BioCryst Pharmaceuticals (BCRX) | 0.0 | $57k | 20k | 2.85 | |
Yield10 Bioscience | 0.0 | $62k | 124k | 0.50 | |
Livent Corp | 0.0 | $67k | 10k | 6.70 | |
Aevi Genomic | 0.0 | $19k | 128k | 0.15 |